Please enable JS

Pharmaceutical Manufacturing

Title Published Pages Region Price
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market Jun 1 2018 125 Asia Pacific $4,995.00
Mosquito-borne Diseases Drug Development Pipeline Review, 2018 May 24 2018 142 Global $3,995.00
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 May 22 2018 112 Global $3,995.00
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence May 1 2018 215 Asia Pacific $4,995.00
Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms May 1 2018 68 Global $6,995.00
Influenza A Viral Infections Drug Development Pipeline Review, 2018 Apr 30 2018 188 Global $3,995.00
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 Apr 30 2018 82 Global $3,995.00
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018 Apr 1 2018 376 Global $3,995.00
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease Apr 1 2018 77 Global $6,995.00
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies Mar 31 2018 92 Asia Pacific $4,995.00
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs Mar 31 2018 181 Global $4,995.00
Fungal Foot Infections Drug Development Pipeline Review, 2018 Mar 22 2018 58 Global $3,995.00
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs Mar 1 2018 148 Asia Pacific $4,995.00
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer’s Disease and SMA Show Clinical and Commercial Potential Feb 7 2018 199 Global $4,995.00
Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market Feb 1 2018 91 Asia Pacific $4,995.00
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies Feb 1 2018 106 Global $2,995.00
Frontier Pharma: Women’s Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline Feb 1 2018 86 Global $6,995.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis Jan 1 2018 79 Global $2,995.00
Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape Dec 1 2017 228 Global $4,995.00
Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape Aug 1 2017 132 Global $4,995.00
Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need Aug 1 2017 79 Global $6,995.00
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis Jul 1 2017 136 Global $4,995.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline May 1 2017 69 Global $2,995.00
Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth May 1 2017 140 Global $4,995.00
Pharmaceutical Lifecycle Management Strategies in 2017 Apr 1 2017 82 Global $2,995.00
Antibacterial Therapies Drug Development Pipeline Review, 2017 Mar 23 2017 418 Global $3,995.00
Neurodegenerative Disorders Drug Development Pipeline Review, 2017 Mar 21 2017 797 Global $3,995.00
Cardiovascular Disorders Drug Development Pipeline Review, 2017 Mar 16 2017 432 Global $3,995.00
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market Mar 1 2017 197 Global $4,995.00
Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs May 1 2016 60 Global $2,995.00

Pages